---
title: "OPCH: Q2 2026 delivered higher revenue, earnings, and cash flow, with positive full-year growth outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294200347.md"
description: "Q2 2026 saw 1.9% revenue growth and 6.7% higher net income, with strong cash flow and $150 million in share repurchases. Full-year guidance projects continued growth in revenue, adjusted EBITDA, and EPS, supported by strategic initiatives and robust market opportunities.Original document: Option Care Health, Inc. [OPCH] SEC 8-K Current Report — Jul. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-29T11:28:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294200347.md)
  - [en](https://longbridge.com/en/news/294200347.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294200347.md)
generator: "portal-rs"
---

# OPCH: Q2 2026 delivered higher revenue, earnings, and cash flow, with positive full-year growth outlook

Q2 2026 saw 1.9% revenue growth and 6.7% higher net income, with strong cash flow and $150 million in share repurchases. Full-year guidance projects continued growth in revenue, adjusted EBITDA, and EPS, supported by strategic initiatives and robust market opportunities.

Original document: Option Care Health, Inc. \[OPCH\] SEC 8-K Current Report — Jul. 29 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [OPCH.US](https://longbridge.com/en/quote/OPCH.US.md)

## Related News & Research

- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Upwork (UPWK) Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/296158870.md)
- [Is Samsung’s $72B payout a vote of confidence in AI?](https://longbridge.com/en/news/296469504.md)
- [PAR Technology survey shows consumer discomfort with restaurant AI drops to 27% in 2026](https://longbridge.com/en/news/296221309.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**